Healthcare utilization after a first hospitalization for COPD: a new approach of State Sequence Analysis based on the '6W' multidimensional model of care trajectories.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
06 Mar 2020
Historique:
received: 30 04 2019
accepted: 24 02 2020
entrez: 8 3 2020
pubmed: 8 3 2020
medline: 18 11 2020
Statut: epublish

Résumé

Published methods to describe and visualize Care Trajectories (CTs) as patterns of healthcare use are very sparse, often incomplete, and not intuitive for non-experts. Our objectives are to propose a typology of CTs one year after a first hospitalization for Chronic Obstructive Pulmonary Disease (COPD), and describe CT types and compare patients' characteristics for each CT type. This is an observational cohort study extracted from Quebec's medico-administrative data of patients aged 40 to 84 years hospitalized for COPD in 2013 (index date). The cohort included patients hospitalized for the first time over a 3-year period before the index date and who survived over the follow-up period. The CTs consisted of sequences of healthcare use (e.g. ED-hospital-home-GP-respiratory therapists, etc.) over a one-year period. The main variable was a CT typology, which was generated by a 'tailored' multidimensional State Sequence Analysis, based on the "6W" model of Care Trajectories. Three dimensions were considered: the care setting ("where"), the reason for consultation ("why"), and the speciality of care providers ("which"). Patients were grouped into specific CT types, which were compared in terms of care use attributes and patients' characteristics using the usual descriptive statistics. The 2581 patients were grouped into five distinct and homogeneous CT types: Type 1 (n = 1351, 52.3%) and Type 2 (n = 748, 29.0%) with low healthcare and moderate healthcare use respectively; Type 3 (n = 216, 8.4%) with high healthcare use, mainly for respiratory reasons, with the highest number of urgent in-hospital days, seen by pulmonologists and respiratory therapists at primary care settings; Type 4 (n = 100, 3.9%) with high healthcare use, mainly cardiovascular, high ED visits, and mostly seen by nurses in community-based primary care; Type 5 (n = 166, 6.4%) with high healthcare use, high ED visits and non-urgent hospitalisations, and with consultations at outpatient clinics and primary care settings, mainly for other reasons than respiratory or cardiovascular. Patients in the 3 highest utilization CT types were older, and had more comorbidities and more severe condition at index hospitalization. The proposed method allows for a better representation of the sequences of healthcare use in the real world, supporting data-driven decision making.

Sections du résumé

BACKGROUND BACKGROUND
Published methods to describe and visualize Care Trajectories (CTs) as patterns of healthcare use are very sparse, often incomplete, and not intuitive for non-experts. Our objectives are to propose a typology of CTs one year after a first hospitalization for Chronic Obstructive Pulmonary Disease (COPD), and describe CT types and compare patients' characteristics for each CT type.
METHODS METHODS
This is an observational cohort study extracted from Quebec's medico-administrative data of patients aged 40 to 84 years hospitalized for COPD in 2013 (index date). The cohort included patients hospitalized for the first time over a 3-year period before the index date and who survived over the follow-up period. The CTs consisted of sequences of healthcare use (e.g. ED-hospital-home-GP-respiratory therapists, etc.) over a one-year period. The main variable was a CT typology, which was generated by a 'tailored' multidimensional State Sequence Analysis, based on the "6W" model of Care Trajectories. Three dimensions were considered: the care setting ("where"), the reason for consultation ("why"), and the speciality of care providers ("which"). Patients were grouped into specific CT types, which were compared in terms of care use attributes and patients' characteristics using the usual descriptive statistics.
RESULTS RESULTS
The 2581 patients were grouped into five distinct and homogeneous CT types: Type 1 (n = 1351, 52.3%) and Type 2 (n = 748, 29.0%) with low healthcare and moderate healthcare use respectively; Type 3 (n = 216, 8.4%) with high healthcare use, mainly for respiratory reasons, with the highest number of urgent in-hospital days, seen by pulmonologists and respiratory therapists at primary care settings; Type 4 (n = 100, 3.9%) with high healthcare use, mainly cardiovascular, high ED visits, and mostly seen by nurses in community-based primary care; Type 5 (n = 166, 6.4%) with high healthcare use, high ED visits and non-urgent hospitalisations, and with consultations at outpatient clinics and primary care settings, mainly for other reasons than respiratory or cardiovascular. Patients in the 3 highest utilization CT types were older, and had more comorbidities and more severe condition at index hospitalization.
CONCLUSIONS CONCLUSIONS
The proposed method allows for a better representation of the sequences of healthcare use in the real world, supporting data-driven decision making.

Identifiants

pubmed: 32143702
doi: 10.1186/s12913-020-5030-0
pii: 10.1186/s12913-020-5030-0
pmc: PMC7059729
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

177

Subventions

Organisme : Canadian Institute of Health Research
ID : CIHR #391051

Références

Artif Intell Med. 2019 May;96:68-79
pubmed: 31164212
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6183-6188
pubmed: 29848627
Stat Methods Med Res. 2019 Jun;28(6):1731-1740
pubmed: 29742976
Stat Methods Med Res. 2019 Jun;28(6):1651-1663
pubmed: 29717944
Respirology. 2011 May;16(4):617-24
pubmed: 21199163
J Hosp Med. 2015 May;10(5):328-39
pubmed: 25820201
Int J Chron Obstruct Pulmon Dis. 2016 Nov 23;11:2897-2908
pubmed: 27920516
BMJ Open. 2016 Jan 22;6(1):e009121
pubmed: 26801463
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
BMC Health Serv Res. 2016 Oct 11;16(1):565
pubmed: 27724877
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
J Am Stat Assoc. 2018;113(521):111-121
pubmed: 30294054
Cochrane Database Syst Rev. 2016 Dec 08;12:CD005305
pubmed: 27930803
Lung. 2017 Aug;195(4):455-461
pubmed: 28474109
Prev Med Rep. 2018 Oct 19;12:284-293
pubmed: 30406006
Fundam Clin Pharmacol. 2018 Feb;32(1):81-84
pubmed: 28921707
Eur Respir J. 2019 May 18;53(5):
pubmed: 30846476
BMC Health Serv Res. 2015 May 15;15:200
pubmed: 25976089
Chest. 2015 Apr;147(4):894-942
pubmed: 25321320
COPD. 2017 Oct;14(5):490-497
pubmed: 28745528
Int J Chron Obstruct Pulmon Dis. 2019 Jan 30;14:331-341
pubmed: 30787603
Annu Rev Public Health. 2009;30:175-201
pubmed: 19296775
Circ Cardiovasc Qual Outcomes. 2015 Oct;8(6 Suppl 3):S131-40
pubmed: 26515201
Soc Sci Res. 2015 Mar;50:76-99
pubmed: 25592922
Respirology. 2018 Jun;23(6):583-592
pubmed: 29265705
Chronic Dis Can. 2000;21(3):104-13
pubmed: 11082346
Public Health. 2018 Apr;157:53-61
pubmed: 29499400
Med Care. 2018 May;56(5):441-447
pubmed: 29578951
Ann Am Thorac Soc. 2014 Mar;11(3):417-24
pubmed: 24423379
Int J Chron Obstruct Pulmon Dis. 2018 Oct 01;13:3045-3054
pubmed: 30319252
J Biomed Inform. 2017 May;69:218-229
pubmed: 28410981
IEEE Trans Vis Comput Graph. 2017 Jun;23(6):1636-1649
pubmed: 28113471

Auteurs

Alain Vanasse (A)

Groupe de recherche PRIMUS, Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada. alain.vanasse@usherbrooke.ca.
Département de médecine de famille et de médecine d'urgence, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada. alain.vanasse@usherbrooke.ca.

Josiane Courteau (J)

Groupe de recherche PRIMUS, Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Mireille Courteau (M)

Groupe de recherche PRIMUS, Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Mike Benigeri (M)

École de santé publique de l'Université de Montréal, 7101 avenue du Parc, Montréal, QC, H3N 1X9, Canada.

Yohann M Chiu (YM)

Département de médecine de famille et de médecine d'urgence, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Isabelle Dufour (I)

Département de médecine de famille et de médecine d'urgence, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Simon Couillard (S)

Service de pneumologie, Département de Médecine, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Pierre Larivée (P)

Service de pneumologie, Département de Médecine, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Catherine Hudon (C)

Groupe de recherche PRIMUS, Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS), 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.
Département de médecine de famille et de médecine d'urgence, Université de Sherbrooke, 3001 12e avenue nord, Sherbrooke, QC, J1H 5N4, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH